Patents by Inventor Christoph Damm
Christoph Damm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230100094Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular including self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which includes a flexible region (9) that can be guided through the aorta.Type: ApplicationFiled: December 5, 2022Publication date: March 30, 2023Applicant: JenaValve Technology, Inc.Inventors: Rudiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 11517431Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular including self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which includes a flexible region (9) that can be guided through the aorta.Type: GrantFiled: October 28, 2019Date of Patent: December 6, 2022Assignee: JenaValve Technology, Inc.Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20220304803Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it, is implanted.Type: ApplicationFiled: June 8, 2022Publication date: September 29, 2022Applicant: JenaValve Technology, Inc.Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
-
Patent number: 11357624Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: December 10, 2019Date of Patent: June 14, 2022Assignee: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Patent number: 11187881Abstract: A method and a device for producing an optical component having at least three monolithically arranged optical functional surfaces and an optical component are disclosed.Type: GrantFiled: November 29, 2016Date of Patent: November 30, 2021Assignees: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., Friedrich-Schiller-Universität JenaInventors: Matthias Beier, Johannes Hartung, Christoph Damm, Stefan Risse, Britta Satzer
-
Patent number: 11116628Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: June 17, 2019Date of Patent: September 14, 2021Assignee: JenaValve Technology, Inc.Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20200179110Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: ApplicationFiled: December 10, 2019Publication date: June 11, 2020Applicant: JenaValve Technology, Inc.Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
-
Publication number: 20200129290Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.Type: ApplicationFiled: October 28, 2019Publication date: April 30, 2020Applicant: JENAVALVE TECHNOLOGY, INC.Inventors: Rüdiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 10543084Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: February 6, 2018Date of Patent: January 28, 2020Assignee: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Publication number: 20190365532Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: June 17, 2019Publication date: December 5, 2019Applicant: JenaValve Technology, Inc.Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 10492906Abstract: A catheter is described for the transvascular implantation of prosthetic heart valves, e.g., including self-expanding anchorage supports, to reduce the risk to the patient during the implantation. Accordingly, a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which includes a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.Type: GrantFiled: September 11, 2017Date of Patent: December 3, 2019Assignee: JenaValve Technology, Inc.Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 10363134Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: November 22, 2017Date of Patent: July 30, 2019Assignee: JenaValve Technology, Inc.Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20190204571Abstract: A method and a device for producing an optical component having at least three monolithically arranged optical functional surfaces and an optical component are disclosed.Type: ApplicationFiled: November 29, 2016Publication date: July 4, 2019Applicants: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., Friedrich-Schiller-Universität Jena, Friedrich-Schiller-Universität JenaInventors: Matthias Beier, Johannes Hartung, Christoph Damm, Stefan Risse, Britta Satzer
-
Publication number: 20190008637Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: ApplicationFiled: February 6, 2018Publication date: January 10, 2019Applicant: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Publication number: 20180318072Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: November 22, 2017Publication date: November 8, 2018Applicant: JenaValve Technology, Inc.Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 9918835Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: April 14, 2016Date of Patent: March 20, 2018Assignee: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Patent number: 9878127Abstract: The invention relates to an operating handle (10-1, 10-2) for manipulating a catheter tip (80-1, 80-2) of a catheter delivery system. The operating handle (10-1, 10-2) comprises a hand grip (11) designed to be held by a user, and a manipulating part (12) axially aligned with the hand grip (11). The manipulating part (12) is rotatable relatively to the hand grip (11) about a longitudinal axis (L) defined by the operating handle (10-1, 10-2). The operating handle (10-1, 10-2) comprises at least one sliding member (30, 40) operatively linked with the manipulating part (12) by means of a cam mechanism (50) such that, upon rotation of the manipulating part (12) relative to the hand grip (11), the at least one sliding member (30, 40) moves axially in the direction of the longitudinal axis (L).Type: GrantFiled: April 10, 2013Date of Patent: January 30, 2018Assignees: JenaValve Technology, Inc., Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V.Inventors: Christoph Damm, Andreas Kamm, Michael Litzenburger, Thomas Töllner
-
Publication number: 20180021132Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.Type: ApplicationFiled: September 11, 2017Publication date: January 25, 2018Applicant: JENAVALVE TECHNOLOGY, INC.Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 9855142Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: June 28, 2016Date of Patent: January 2, 2018Assignee: JenaValve Technologies, Inc.Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 9788945Abstract: The invention relates to a catheter for the transvasculur implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) riming the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.Type: GrantFiled: March 21, 2017Date of Patent: October 17, 2017Assignee: JENAVALVE TECHNOLOGY, INC.Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm